FDA Warning Letter Explorer
Drugs · Letter issue date: Apr 12, 2021

Hou Fu Biotech - Jiangsu Co., Ltd

5 extracted findings · 3 model-assigned issue types

FDA source excerpt, selected passage

FDA laboratory testing of a batch of this product detained at the border found that the drug product contained an average of only 45% v/v ethanol. This hand sanitizer drug product is adulterated under section 501(c) of the FD&C Act in that the active ingredient of ethanol is present at levels in the product lower than…

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Labeling, claims & marketing

The product is adulterated under section 501(c) because it contains less ethanol than declared on the label.

Supporting FDA text
Source excerpt · automated text-match check

FDA laboratory testing of a batch of this product detained at the border found that the drug product contained an average of only 45% v/v ethanol. This hand sanitizer drug product is adulterated under section 501(c) of the FD&C Act in that the active ingredient of ethanol is present at levels in the product lower than that which is declared on its label.

Quality unit & oversight

The subpotency demonstrates that quality assurance is not functioning in accordance with CGMP requirements.

Supporting FDA text
Source excerpt · automated text-match check

The subpotency of hand sanitizer drug products declared to be manufactured in your facility demonstrates that the quality assurance within your facility is not functioning in accordance with CGMP requirements under section 501(a)(2)(B) of the FD&C Act.

Registration, listing & premarket

The product is an unapproved new drug introduced into interstate commerce without FDA approval.

Supporting FDA text
Source excerpt · automated text-match check

PANROSA Instant Hand Sanitizer is an unapproved new drug introduced or delivered for introduction into interstate commerce in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a)

Labeling, claims & marketing21 CFR 330.1(g)

The product is misbranded under section 502(f)(2) because it lacks required warning statements.

Supporting FDA text
Source excerpt · automated text-match check

PANROSA Instant Hand Sanitizer is also misbranded under section 502(f)(2) of the FD&C Act 21 U.S.C.352(f)(2), because the product label does not include all of the applicable warnings as required under 21 CFR 330.1(g). Specifically, the label does not include the warning statement that reads, “If swallowed, get medical help or contact a Poison Control Center right away.”

Registration, listing & premarket

The product is misbranded under section 502(ee) because it does not comply with requirements for marketing under section 505G.

Supporting FDA text
Source excerpt · automated text-match check

this product is misbranded under section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee) because PANROSA Instant Hand Sanitizer is a nonprescription drug subject to section 505G of the FD&C Act, 21 U.S.C. 355h, but does not comply with the requirements for marketing under that section and is not the subject of an application approved under section 505 of the FD&C Act, 21 U.S.C. 355.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

01
FDA laboratory testing of a batch of this product detained at the border found that the drug product contained an average of only 45% v/v ethanol. This hand sanitizer drug product is adulterated under section 501(c) of the FD&C Act in that the active ingredient of ethanol is present at levels in the product lower than that which is declared on its label.

Source passage selected by the model

02
The subpotency of hand sanitizer drug products declared to be manufactured in your facility demonstrates that the quality assurance within your facility is not functioning in accordance with CGMP requirements under section 501(a)(2)(B) of the FD&C Act.

Source passage selected by the model

03
PANROSA Instant Hand Sanitizer is an unapproved new drug introduced or delivered for introduction into interstate commerce in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a)

Source passage selected by the model

04
PANROSA Instant Hand Sanitizer is also misbranded under section 502(f)(2) of the FD&C Act 21 U.S.C.352(f)(2), because the product label does not include all of the applicable warnings as required under 21 CFR 330.1(g). Specifically, the label does not include the warning statement that reads, “If swallowed, get medical help or contact a Poison Control Center right away.”

Source passage selected by the model

05
this product is misbranded under section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee) because PANROSA Instant Hand Sanitizer is a nonprescription drug subject to section 505G of the FD&C Act, 21 U.S.C. 355h, but does not comply with the requirements for marketing under that section and is not the subject of an application approved under section 505 of the FD&C Act, 21 U.S.C. 355.

Source passage selected by the model

What FDA requested

Model-assisted summary. Consult the letter for complete requests and conditions.

  • A detailed investigation into how the hand sanitizer drug product described above, which was labeled as containing 70% ethanol, in fact contained an average of 45% ethanol.
  • A list of all raw materials used to manufacture all of your hand sanitizer drug products, including the suppliers’ names, addresses, and contact information.
  • A list of all batches of any hand sanitizer drug products shipped to the United States by your firm, and a full reconciliation of all material you distributed.
  • Copies of the complete batch records for all batches distributed to the U.S.

Sections and clauses cited

As cited in this historical letter, not a statement of current regulatory requirements.

Keep exploring

More drug letters

Recent records for the same product type. Your previous filters remain available when you return.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.